These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33664598)

  • 41. Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy: the ILUCYD study.
    Motloch K; Soler V; Delyfer MN; Vasseur V; Wolff B; Issa M; Dot C; Massé H; Weber M; Comet A; Hitzl W; Matonti F; Creuzot-Garcher C; Tadayoni R; Kodjikian L; Couturier A
    Ophthalmol Retina; 2024 Jul; ():. PubMed ID: 39004282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
    Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant - A Case Report.
    Meira J; Madeira C; Falcão-Reis F; Figueira L
    Ophthalmol Ther; 2019 Dec; 8(4):635-641. PubMed ID: 31506865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia.
    Cachero Rodríguez JM; Artaraz J; Imaz N; Fonollosa A
    J Ophthalmic Inflamm Infect; 2024 May; 14(1):19. PubMed ID: 38700565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results.
    Boscia F; Furino C; Dammacco R; Ferreri P; Sborgia L; Sborgia C
    Eur J Ophthalmol; 2005; 15(1):89-95. PubMed ID: 15751245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.
    Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C
    Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 µg intravitreal implant in people with diabetic macular edema.
    Holden SE; Currie CJ; Owens DR
    Curr Med Res Opin; 2017 Oct; 33(sup2):5-17. PubMed ID: 28881149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis.
    Hikal M; Celik N; Auffarth GU; Kessler LJ; Mayer CS; Khoramnia R
    J Clin Med; 2021 Sep; 10(17):. PubMed ID: 34501414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant.
    Baillif S; Staccini P; Weber M; Delyfer MN; Le Mer Y; Gualino V; Collot L; Merite PY; Creuzot-Garcher C; Kodjikian L; Massin P
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE.
    Elbarky AM
    Clin Ophthalmol; 2020; 14():823-830. PubMed ID: 32214793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN
    Augustin AJ; Bopp S; Fechner M; Holz F; Sandner D; Winkgen AM; Khoramnia R; Neuhann T; Warscher M; Spitzer M; Sekundo W; Seitz B; Duncker T; Ksinsik C; Höh H; Gentsch D
    Eur J Ophthalmol; 2020 Mar; 30(2):382-391. PubMed ID: 30884972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANT FOR RADIATION RETINOPATHY: Report of Preliminary Findings.
    Singaravelu J; Oakey ZB; Wrenn JM; Singh AD
    Retina; 2023 Aug; 43(8):1364-1369. PubMed ID: 37027785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative technique for the injection of fluocinolone acetonide (FAc) intravitreal implant (Iluvien
    Diago T; Fau SG; Roca JM
    Eur J Ophthalmol; 2023 May; 33(3):1501-1505. PubMed ID: 36632008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.
    Guclu H; Pelitli Gurlu V
    Int J Ophthalmol; 2019; 12(2):258-267. PubMed ID: 30809482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema - A Single Center Study.
    Soares RM; Ferreira CC; Fernandes JDS; Madeira C; Silva LMA; Saraiva E; Ribeiro L; Fonseca S
    Clin Ophthalmol; 2024; 18():1057-1066. PubMed ID: 38646183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study.
    Deuchler SK; Schubert R; Singh P; Chedid A; Kenikstul N; Scott J; Kohnen T; Ackermann H; Koch F
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2537-2547. PubMed ID: 35239010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.